(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||
Earning before tax | ---- | 4,539.68%43.38M | ---- | 100.26%935K | --16.47M | -227.53%-362.66M | ---110.73M |
Profit adjustment | |||||||
Investment loss (gain) | ---- | 5.12%5.68M | ---- | 20.03%5.41M | --2.67M | 296.42%4.5M | ---2.29M |
Impairment and provisions: | ---- | 423.40%18.41M | ---- | -67.69%3.52M | --1.38M | 217.84%10.89M | --3.43M |
-Other impairments and provisions | ---- | 423.40%18.41M | ---- | -67.69%3.52M | --1.38M | 217.84%10.89M | --3.43M |
Revaluation surplus: | ---- | ---4.55M | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---4.55M | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | 54.50%-1.82M | ---- | 52.13%-4M | --426K | 29.26%-8.36M | ---11.81M |
-Loss (gain) from sale of subsidiary company | ---- | 50.11%-1.62M | ---- | ---3.24M | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 73.32%-202K | ---- | 90.94%-757K | --426K | 29.26%-8.36M | ---11.81M |
Depreciation and amortization: | ---- | 10.88%188.03M | ---- | 10.81%169.58M | --84.82M | 20.46%153.05M | --127.05M |
-Amortization of intangible assets | ---- | 10.37%3.33M | ---- | 104.54%3.02M | --1.29M | 140.23%1.48M | --614K |
Financial expense | ---- | -33.98%21.53M | ---- | -46.66%32.61M | --12.86M | -49.29%61.13M | --120.54M |
Special items | ---- | -19.13%2.6M | ---- | -98.90%3.22M | --1.61M | 8,387.38%291.12M | --3.43M |
Operating profit before the change of operating capital | ---- | 29.35%273.26M | ---- | 41.16%211.26M | --120.22M | 15.47%149.67M | --129.61M |
Change of operating capital | |||||||
Inventory (increase) decrease | ---- | 486.40%1.34M | ---- | 122.66%228K | ---1.38M | -105.90%-1.01M | --17.04M |
Accounts receivable (increase)decrease | ---- | 131.73%7.22M | ---- | 82.21%-22.76M | ---31.78M | 2.64%-127.96M | ---131.44M |
Accounts payable increase (decrease) | ---- | -242.89%-11.85M | ---- | 225.68%8.3M | ---9.46M | -80.49%2.55M | --13.06M |
Special items for working capital changes | ---- | -729.13%-60.2M | ---- | 100.99%9.57M | --4.33M | -89.74%4.76M | --46.4M |
Cash from business operations | -62.21%38.48M | 1.53%209.77M | 24.29%101.83M | 637.64%206.6M | --81.93M | -62.49%28.01M | --74.67M |
Other taxs | 15.70%-5.28M | 14.66%-11.23M | 1.09%-6.26M | -19.12%-13.16M | ---6.33M | -141.73%-11.05M | ---4.57M |
Interest received - operating | -49.81%927K | -38.75%2.9M | -24.21%1.85M | 355.25%4.73M | --2.44M | 142.19%1.04M | --429K |
Net cash from operations | -64.97%34.13M | 1.65%201.44M | 24.83%97.42M | 1,000.94%198.17M | --78.04M | -74.48%18M | --70.53M |
Cash flow from investment activities | |||||||
Loan receivable (increase) decrease | --600K | ---3.45M | ---- | ---- | ---- | ---- | --2.71M |
Sale of fixed assets | -99.93%1K | -66.73%2.45M | -70.53%1.54M | -71.64%7.35M | --5.22M | -7.65%25.91M | --28.06M |
Purchase of fixed assets | -283.51%-179.31M | 65.45%-92.32M | 47.49%-46.76M | -93.64%-267.19M | ---89.04M | 41.65%-137.98M | ---236.5M |
Purchase of intangible assets | 84.57%-992K | 5.47%-4.2M | -254.33%-6.43M | 5.43%-4.44M | ---1.82M | -67.32%-4.7M | ---2.81M |
Sale of subsidiaries | 2,265.85%2.91M | -98.57%634K | -97.79%123K | --44.47M | --5.57M | ---- | ---- |
Acquisition of subsidiaries | ---- | ---2.3M | ---- | ---- | ---- | -1,311.62%-8.26M | ---585K |
Recovery of cash from investments | --1.4M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---- | 43.63%-17.88M | -624.62%-14.13M | -21.95%-31.72M | ---1.95M | -263.78%-26.01M | ---7.15M |
Net cash from investment operations | -167.13%-175.39M | 53.46%-117.07M | 19.96%-65.66M | -66.54%-251.54M | ---82.03M | 30.16%-151.03M | ---216.27M |
Net cash before financing | -544.78%-141.26M | 258.08%84.36M | 896.79%31.76M | 59.88%-53.37M | ---3.99M | 8.72%-133.03M | ---145.74M |
Cash flow from financing activities | |||||||
New borrowing | 323.88%120.73M | -54.47%70.38M | -50.45%28.48M | -12.71%154.6M | --57.48M | -42.67%177.1M | --308.94M |
Refund | 29.21%-25.11M | -23.17%-85.22M | -1.62%-35.47M | 48.54%-69.19M | ---34.91M | -22.28%-134.46M | ---109.96M |
Issuing shares | --242.96M | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | 14.90%-11.02M | 33.55%-25.21M | 16.95%-12.95M | 21.28%-37.94M | ---15.6M | -5.66%-48.2M | ---45.62M |
Dividends paid - financing | ---1.53M | ---- | ---- | -70.42%-1.23M | ---937K | ---720K | ---- |
Absorb investment income | 225.58%700K | -3.72%3.6M | -92.29%215K | -99.41%3.73M | --2.79M | 84.69%629.37M | --340.77M |
Issuance expenses and redemption of securities expenses | -217.79%-9.08M | -211.00%-5.85M | ---2.86M | 26.88%-1.88M | ---- | ---2.57M | ---- |
Other items of the financing business | 109.85%2M | -972.98%-40.42M | -1,014,200.00%-20.29M | -150.15%-3.77M | ---2K | 137.27%7.51M | ---20.15M |
Adjustment item of financing business | ---- | ---- | ---- | ---- | ---133K | ---- | ---- |
Net cash from financing operations | 288.20%257.96M | -144.41%-235.72M | -72.51%-137.07M | -121.29%-96.45M | ---79.46M | 51.98%452.92M | --298.02M |
Net Cash | 210.81%116.7M | -1.03%-151.36M | -26.21%-105.31M | -146.83%-149.81M | ---83.44M | 110.07%319.89M | --152.28M |
Begining period cash | -44.49%188.84M | -30.57%340.19M | -30.57%340.19M | 188.04%490.01M | --490.01M | 853.64%170.12M | --17.84M |
Cash at the end | 30.08%305.54M | -44.49%188.84M | -42.23%234.88M | -30.57%340.19M | --406.57M | 188.04%490.01M | --170.12M |
Cash balance analysis | |||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data